Alteration in phosphorylation of P20 is associated with insulin resistance.

We have recently identified a small phosphoprotein, P20, as a common intracellular target for insulin and several of its antagonists, including amylin, epinephrine, and calcitonin gene-related peptide. These hormones elicit phosphorylation of P20 at its different sites, producing three phosphorylated isoforms: S1 with an isoelectric point (pI) value of 6.0, S2 with a pI value of 5.9, and S3 with a pI value of 5.6 (FEBS Letters 457:149-152 and 462:25-30, 1999). In the current study, we showed that P20 is one of the most abundant phosphoproteins in rat extensor digitorum longus (EDL) muscle. Insulin and amylin antagonize each other's actions in the phosphorylation of this protein in rat EDL muscle. Insulin inhibits amylin-evoked phosphorylation of S2 and S3, whereas amylin decreases insulin-induced phosphorylation of S1. In rats made insulin resistant by dexamethasone treatment, levels of the phosphoisoforms S2 and S3, which were barely detectable in healthy rats in the absence of hormone stimulation, were significantly increased. Moreover, the ability of insulin to inhibit amylin-evoked phosphorylation of these two isoforms was greatly attenuated. These results suggested that alterations in the phosphorylation of P20 might be associated with insulin resistance and that P20 could serve as a useful marker to dissect the cellular mechanisms of this disease.

[1]  G. Cooper,et al.  Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro , 1988, Nature.

[2]  J. Rothbard,et al.  Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[3]  J. Olefsky,et al.  Induction of Insulin Resistance In Vivo by Amylin and Calcitonin Gene–Related Peptide , 1990, Diabetes.

[4]  J. Foley,et al.  Effects of amylin on glucose metabolism and glycogenolysis in vivo and in vitro. , 1990, The American journal of physiology.

[5]  G. Cooper,et al.  Amylin injection causes elevated plasma lactate and glucose in the rat , 1991, FEBS letters.

[6]  J. Flier,et al.  Insulin resistance--mechanisms, syndromes, and implications. , 1991, The New England journal of medicine.

[7]  L. Rossetti,et al.  In Vivo Insulin Resistance Induced by Amylin Primarily Through Inhibition of Insulin-Stimulated Glycogen Synthesis in Skeletal Muscle , 1991, Diabetes.

[8]  M. Nakazato,et al.  Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus. , 1992, Diabetes research and clinical practice.

[9]  F. Giorgino,et al.  Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo. , 1993, The Journal of clinical investigation.

[10]  D. James,et al.  Glucose transport in L6 myoblasts overexpressing GLUT1 and GLUT4. , 1993, The Journal of biological chemistry.

[11]  R. Unger,et al.  Amylin-insulin relationships in insulin resistance with and without diabetic hyperglycemia. , 1993, The American journal of physiology.

[12]  K. Kato,et al.  Purification and characterization of a 20-kDa protein that is highly homologous to alpha B crystallin. , 1994, The Journal of biological chemistry.

[13]  G. Cooper.  Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease. , 1994, Endocrine reviews.

[14]  C. R. Kahn,et al.  Insulin Action, Diabetogenes, and the Cause of Type II Diabetes , 1994, Diabetes.

[15]  A. Klip,et al.  Disassembly of the actin network inhibits insulin-dependent stimulation of glucose transport and prevents recruitment of glucose transporters to the plasma membrane. , 1994, The Journal of biological chemistry.

[16]  G. Reaven,et al.  Pathophysiology of insulin resistance in human disease. , 1995, Physiological reviews.

[17]  K. Kato,et al.  cDNA cloning of a 20-kDa protein (p20) highly homologous to small heat shock proteins: developmental and physiological changes in rat hindlimb muscles. , 1996, Gene.

[18]  C. Kahn,et al.  Overexpression of Rad Inhibits Glucose Uptake in Cultured Muscle and Fat Cells* , 1996, The Journal of Biological Chemistry.

[19]  D. Moller,et al.  Candidate Genes for Insulin Resistance , 1996, Diabetes Care.

[20]  J. Zierath,et al.  Insulin Receptor Substrate-1 Phosphorylation and Phosphatidylinositol 3-Kinase Activity in Skeletal Muscle From NIDDM Subjects After In Vivo Insulin Stimulation , 1997, Diabetes.

[21]  M. Heller,et al.  Rat amylin-(8-37) enhances insulin action and alters lipid metabolism in normal and insulin-resistant rats. , 1997, American journal of physiology. Endocrinology and metabolism.

[22]  G. Cooney,et al.  Mechanisms of Liver and Muscle Insulin Resistance Induced by Chronic High-Fat Feeding , 1997, Diabetes.

[23]  H. Rasmussen,et al.  Cyclic Nucleotide-dependent Vasorelaxation Is Associated with the Phosphorylation of a Small Heat Shock-related Protein* , 1997, The Journal of Biological Chemistry.

[24]  G. Dimitriadis,et al.  Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle. , 1997, The Biochemical journal.

[25]  R. DeFronzo.  PATHOGENESIS OF TYPE 2 DIABETES: METABOLIC AND MOLECULAR IMPLICATIONS FOR IDENTIFYING DIABETES GENES , 1997 .

[26]  C. Betsholtz,et al.  Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin). , 1998, Biochemical and biophysical research communications.

[27]  B. Kahn.  Type 2 Diabetes: When Insulin Secretion Fails to Compensate for Insulin Resistance , 1998, Cell.

[28]  S. Hunter,et al.  Insulin action and insulin resistance: diseases involving defects in insulin receptors, signal transduction, and the glucose transport effector system. , 1998, The American journal of medicine.

[29]  J. Ivy,et al.  Amylin influences insulin-stimulated glucose metabolism by two independent mechanisms. , 1998, American journal of physiology. Endocrinology and metabolism.

[30]  F. Andreozzi,et al.  PED/PEA‐15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus , 1998, The EMBO journal.

[31]  G. Boden.  Free fatty acids (FFA), a link between obesity and insulin resistance. , 1998, Frontiers in bioscience : a journal and virtual library.

[32]  P. Björntorp.  Neuroendocrine perturbations as a cause of insulin resistance , 1999, Diabetes/metabolism research and reviews.

[33]  G. Cooper,et al.  Amylin evokes phosphorylation of P20 in rat skeletal muscle , 1999, FEBS letters.

[34]  R. Pearson,et al.  Insulin and insulin antagonists evoke phosphorylation of P20 at serine 157 and serine 16 respectively in rat skeletal muscle , 1999, FEBS letters.

[35]  M Morfis,et al.  Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. , 1999, Molecular pharmacology.

[36]  A. Graham,et al.  The small heat shock-related protein-20 is an actin-associated protein. , 1999, Journal of vascular surgery.

[37]  A. Saltiel,et al.  Aldolase Mediates the Association of F-actin with the Insulin-responsive Glucose Transporter GLUT4* , 1999, The Journal of Biological Chemistry.

[38]  H. Rasmussen,et al.  Phosphorylation events associated with cyclic nucleotidedependent inhibition of smooth muscle contraction. , 1999, American journal of physiology. Heart and circulatory physiology.

[39]  B. Walker,et al.  Glucocorticoids and insulin resistance: old hormones, new targets. , 1999, Clinical science.

[40]  O. Kozawa,et al.  Small molecular weight heat shock-related protein, HSP20, exhibits an anti-platelet activity by inhibiting receptor-mediated calcium influx. , 1999, Life sciences.